Stimulant, Antidepressant, and Opioid Telehealth Prescription Trends Between 2019 and 2022
This cross-sectional study examines the rates of in-person and telehealth prescriptions for stimulants, antidepressants, and opioids before and during the COVID-19 pandemic.
Authors
- Austin B. Miller (ORCID: https://orcid.org/0000-0001-5508-3147)
- Sanjula Jain
- Ashwini Nagappan (ORCID: https://orcid.org/0000-0001-5518-102X)
- Allison H. Oakes (ORCID: https://orcid.org/0000-0003-1516-0034)
Institutions
- Saint Thomas Health (US)
- Johns Hopkins University (US)
- UCLA Health (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.33334
- Citations
- 9
- Primary Topic
- Telemedicine and Telehealth Implementation
- Type
- article
- Field-Weighted Citation Impact
- 4.89
Funders
- National Institutes of Health
- Clinical and Translational Science Institute, University of California, Los Angeles